ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 23 of 3322 for:    Louisville

A Study of Cisplatin or Carboplatin With Gemcitabine Versus Gemcitabine Alone as Adjuvant Therapy in Patients With Resected or Ablation Intra-Hepatic Cholangiocarcinoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03081039
Recruitment Status : Withdrawn (Competing study)
First Posted : March 15, 2017
Last Update Posted : February 19, 2018
Sponsor:
Information provided by (Responsible Party):
Robert C. Martin, University of Louisville

No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Recruitment Status : Withdrawn
  Estimated Primary Completion Date : April 28, 2022
  Estimated Study Completion Date : December 31, 2022